These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 935792)

  • 21. Effect of chronic atenolol therapy on the cardiovascular response to handgrip in hypertensive patients.
    Orlandi C; Fogari R
    Clin Ther; 1983; 5(6):632-7. PubMed ID: 6627289
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative study of stress reactions during oral surgery after pindolol and metoprolol.
    Brisse B; Tetsch P; Schwill E; Bender F
    J Pharmacol; 1983; 14 Suppl 2():21-9. PubMed ID: 6314054
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effect of pindolol (Visken) on blood pressure and plasma renin activity in various forms of hypertension].
    Werning C; Vetter H
    Adv Clin Pharmacol; 1976; 11():54-60. PubMed ID: 1032571
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Problems of adaptation in hypertension research (author's transl)].
    Neus H; von Eiff AW; Friedrich G; Heusch G; Schulte W
    Dtsch Med Wochenschr; 1981 May; 106(19):622-4. PubMed ID: 7215192
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The efficiency of coronary therapy with Visken (pindolol). A combined clinical and experimental analysis (author's transl)].
    Delius L; Lübke KO
    Med Klin; 1974 Jun; 69(25):1117-23. PubMed ID: 4602393
    [No Abstract]   [Full Text] [Related]  

  • 26. [Treatment of supraventricular arrhythmias using the beta-blockader Visken].
    Zdichynec B
    Z Arztl Fortbild (Jena); 1977 May; 71(10):478. PubMed ID: 910468
    [No Abstract]   [Full Text] [Related]  

  • 27. [Clinical pharmacology of the beta-adrenolytic activity of pindolol].
    Hugues FC; Julien D; Munera Y; Heams D; Marche J
    Therapie; 1976; 31(2):179-93. PubMed ID: 7858
    [No Abstract]   [Full Text] [Related]  

  • 28. [Effect of beta blockers with intrinsic sympathomimetic activity on blood pressure and blood lipids in patients with essential hypertension].
    Serro-Azul JB; Wajngarten M; Santomauro A; Braga A; Yazbek Júnior P; Bellotti G; Serro-Azul LG; Pileggi F
    Arq Bras Cardiol; 1989 Dec; 53(6):321-5. PubMed ID: 2700113
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pindolol eye drops (Glauco-Visken) - half year's results in glaucoma therapy].
    Merté HJ; Stryz JR; Mertz M
    Klin Monbl Augenheilkd; 1984 Mar; 184(3):227-32. PubMed ID: 6374263
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The cardiotropic effect of the beta receptor blockader Prindolol].
    Fiegel G
    Med Welt; 1975 Oct; 26(43):1989-9. PubMed ID: 1196090
    [No Abstract]   [Full Text] [Related]  

  • 31. Influence of beta-blockade with beta-1-selectivity or intrinsic sympathomimetic activity on some cardiorespiratory responses to exercise.
    Yonga GO; Oyuga HW; Njeru EK
    East Afr Med J; 1993 Jul; 70(7):405-8. PubMed ID: 7904931
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Cardiovascular response to mental stress, dynamic and isometric exercise in a group of hypertensive patients treated with prizidilol (SK&F 92657)].
    Caldari R; Borghi C; Costa FC; Strocchi E; Ambrosioni E
    Cardiologia; 1982; 27(7):635-42. PubMed ID: 6927494
    [No Abstract]   [Full Text] [Related]  

  • 33. [The effect of beta-adrenergic blocking agents on plasma renin activity (author's transl)].
    Slabý A; Dosková M; Horký K; Kopecká J; Reisenauer R
    Sb Lek; 1973 Nov; 75(11):355-63. PubMed ID: 4762672
    [No Abstract]   [Full Text] [Related]  

  • 34. [Effects of LBI45, practolol and a placebo on the exercise tests of coronary patients. A double-blind study (author's transl)].
    Bloch A; Horvat L
    Schweiz Rundsch Med Prax; 1974 Jan; 63(3):62-5. PubMed ID: 4605646
    [No Abstract]   [Full Text] [Related]  

  • 35. Treatment of hypertension with a new beta-blocking agent, pindolol (Visken).
    Persson I; Ulrich J
    Eur J Clin Pharmacol; 1973 Dec; 6(4):217-9. PubMed ID: 4591149
    [No Abstract]   [Full Text] [Related]  

  • 36. Effects of chronic beta-adrenoceptor blockade on variability in blood pressure and heart rate: a non-invasive spectral study.
    Girard A; Laude D; Japundzic N; Elghozi JL
    J Hypertens Suppl; 1991 Dec; 9(6):S350-1. PubMed ID: 1687871
    [No Abstract]   [Full Text] [Related]  

  • 37. [Pharmacodynamic effects of the beta-blocker mepindolol administered transdermally to healthy volunteers].
    Liedtke RK
    Schweiz Rundsch Med Prax; 1987 Jul; 76(30-31):854-6. PubMed ID: 2889251
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of visken on the circulation and respiration in the postoperative period.
    Pulay I; Weltner J; Darvas K; Alánt O
    Ther Hung; 1979; 27(4):185-8. PubMed ID: 538750
    [No Abstract]   [Full Text] [Related]  

  • 39. Chronic effects of bunitrolol and pindolol on blood pressure, heart rate, vascular lesions, and plasma renin activity in hypertensive rats.
    Hasegawa Y; Watanabe TX; Kawashima K; Sokabe H; Saito K
    Jpn J Pharmacol; 1982 Aug; 32(4):742-5. PubMed ID: 6127427
    [No Abstract]   [Full Text] [Related]  

  • 40. A pharmacodynamic and pharmacokinetic comparison of pindolol 20 mg retard and a conventional tablet.
    Aellig WH; Narjes HH; Nüesch E; Oertle RJ; Devos JE; Pacha W
    Eur J Clin Pharmacol; 1981; 20(3):179-83. PubMed ID: 7286035
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.